Ram Vilas Paswan, Honble Minister for Steel, Chemicals and Fertilisers, has laid the foundation stone of IDPLs Cephalosporin Block at Indian Drugs & Pharmaceuticals Limited (IDPL) Gurgaon Plant.
The new store will be a state of the art, schedule M compliant / WHO-GMP formulation block for the production of Cephalosporin formulations. It will be spread over five acres and will involve a capital expenditure of Rs.13 crores in the first phase. The new plant will also generate employment for 150 people.
The Cephalosporin plant would be people, product & environment friendly using modern technology, solar energy and rain water harvesting etc. wherever possible. In the first phase, the new Cephalosporin block will have the facilities for the manufacture of Cephalosporin tablets and in the second phase injectibles and other dosage formulations will be covered.
IDPL also signed two MOUs with National Institute of Pharmaceutical Education and Research (NIPER), Mohali an Institute of national importance under the Ministry of Chemicals and Fertilisers. The first MOU is for the manufacture of Zinc Dispersible tablets under which the technology is being transferred free of cost by NIPER to IDPL. This will enable IDPL to address the incidence of child mortality due to Diarrhoae , as Zinc Sulphate has been prescribed as an adjunct therapy in the treatment of acute and persistent non-dysentery diarrhoea in children by WHO in 2005.
The other dignitaries present on the occasion were B.K Handique, Honble Union Minister of State for Chemicals & Fertilizers and Mines, Rao Inderjit Singh, Honble Union Minister of State for Defence Production, Ashok Kumar, Secretary (Pharma), Smt. Satwant Reddy, Chairperson, Bureau of Pharma PSUs of India (BPPI), etc. IDPL has witnessed exceptional growth in the last few years with the turnover jumping from Rs72mn in 2005-06 to the Rs621mn in 2007-08. The company is expected to close this year with a turnover of Rs1.25bn.
Dr. Jayashree Gupta, CMD, IDPL addressed the gathering and talked about the role that IDPL is expected to play to further change the medical scenario in India. Dr. Jayashree Gupta said, "IDPL has been in the forefront whenever the nation has been confronted with health emergencies and has acted swiftly & responsibly to produce and supply required medicines in the shortest timeframe". She added that IDPL has turned around in the last three years and is hopeful that the company will continue with its impressive growth in times to come backed by new initiatives like the launch of OTC drugs, Jan Aushadhi Stores etc.
|
